within Pharmacolibrary.Drugs.D_Dermatologicals.D01A_AntifungalsForTopicalUse.D01AE14_Ciclopirox;

model Ciclopirox
  extends Pharmacolibrary.Drugs.ATC.D.D01AE14;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>D01AE14</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Ciclopirox is a synthetic antifungal agent used topically to treat superficial fungal infections of the skin and nails, such as dermatophytoses, candidiasis, and tinea versicolor. It is approved for clinical use in many countries, primarily for topical application as creams, lotions, gels, and lacquers.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for topical ciclopirox in healthy adults, as available literature does not provide detailed systemic PK measurements due to its minimal systemic absorption.</p><h4>References</h4><ol><li><p>Gupta, AK, &amp; Talukder, M (2022). Efinaconazole in Onychomycosis. <i>American journal of clinical dermatology</i> 23(2) 207–218. DOI:<a href=&quot;https://doi.org/10.1007/s40257-021-00660-1&quot;>10.1007/s40257-021-00660-1</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34902110/&quot;>https://pubmed.ncbi.nlm.nih.gov/34902110</a></p></li><li><p>Bohn, M, &amp; Kraemer, KT (2000). Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis. <i>Journal of the American Academy of Dermatology</i> 43(4 Suppl) S57–S69. DOI:<a href=&quot;https://doi.org/10.1067/mjd.2000.109072&quot;>10.1067/mjd.2000.109072</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11051135/&quot;>https://pubmed.ncbi.nlm.nih.gov/11051135</a></p></li><li><p>Gupta, AK, et al., &amp; Foley, KA (2014). Topical therapy for toenail onychomycosis: an evidence-based review. <i>American journal of clinical dermatology</i> 15(6) 489–502. DOI:<a href=&quot;https://doi.org/10.1007/s40257-014-0096-2&quot;>10.1007/s40257-014-0096-2</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25257931/&quot;>https://pubmed.ncbi.nlm.nih.gov/25257931</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Ciclopirox;
